Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

577 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression profiling by microarrays in colorectal cancer (Review).
Shih W, Chetty R, Tsao MS. Shih W, et al. Among authors: tsao ms. Oncol Rep. 2005 Mar;13(3):517-24. Oncol Rep. 2005. PMID: 15706427 Review.
Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers.
Tsao MS, Liu N, Chen JR, Pappas J, Ho J, To C, Viallet J, Park M, Zhu H. Tsao MS, et al. Lung Cancer. 1998 Apr;20(1):1-16. doi: 10.1016/s0169-5002(98)00007-5. Lung Cancer. 1998. PMID: 9699182
Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras.
Catzavelos C, Tsao MS, DeBoer G, Bhattacharya N, Shepherd FA, Slingerland JM. Catzavelos C, et al. Among authors: tsao ms. Cancer Res. 1999 Feb 1;59(3):684-8. Cancer Res. 1999. PMID: 9973218
Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer.
Tsao MS, Yang Y, Marcus A, Liu N, Mou L. Tsao MS, et al. Hum Pathol. 2001 Jan;32(1):57-65. doi: 10.1053/hupa.2001.21133. Hum Pathol. 2001. PMID: 11172296
High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells.
To C, Seiden I, Liu N, Wigle D, Tsao MS. To C, et al. Among authors: tsao ms. Exp Cell Res. 2002 Feb 1;273(1):45-53. doi: 10.1006/excr.2001.5433. Exp Cell Res. 2002. PMID: 11795945
Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.
Wigle DA, Jurisica I, Radulovich N, Pintilie M, Rossant J, Liu N, Lu C, Woodgett J, Seiden I, Johnston M, Keshavjee S, Darling G, Winton T, Breitkreutz BJ, Jorgenson P, Tyers M, Shepherd FA, Tsao MS. Wigle DA, et al. Among authors: tsao ms. Cancer Res. 2002 Jun 1;62(11):3005-8. Cancer Res. 2002. PMID: 12036904
Novel candidate tumor marker genes for lung adenocarcinoma.
Wang KK, Liu N, Radulovich N, Wigle DA, Johnston MR, Shepherd FA, Minden MD, Tsao MS. Wang KK, et al. Among authors: tsao ms. Oncogene. 2002 Oct 24;21(49):7598-604. doi: 10.1038/sj.onc.1205953. Oncogene. 2002. PMID: 12386823
Dysregulated PTEN-PKB and negative receptor status in human breast cancer.
Shi W, Zhang X, Pintilie M, Ma N, Miller N, Banerjee D, Tsao MS, Mak T, Fyles A, Liu FF. Shi W, et al. Among authors: tsao ms. Int J Cancer. 2003 Mar 20;104(2):195-203. doi: 10.1002/ijc.10909. Int J Cancer. 2003. PMID: 12569575
Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.
Long IS, Han K, Li M, Shirasawa S, Sasazuki T, Johnston M, Tsao MS. Long IS, et al. Among authors: tsao ms. Mol Cancer Res. 2003 Mar;1(5):393-401. Mol Cancer Res. 2003. PMID: 12651912
Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.
Blackhall FH, Pintilie M, Michael M, Leighl N, Feld R, Tsao MS, Shepherd FA. Blackhall FH, et al. Among authors: tsao ms. Clin Cancer Res. 2003 Jun;9(6):2241-7. Clin Cancer Res. 2003. PMID: 12796392
577 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback